Antonia Andonova, PhD

Research Scientist

Antonia has excelled in various academic, clinical, and research-based settings. Her expertise lies in both quantitative and qualitative research methods, as well as evaluations. She has a strong background in evidence synthesis, health economics, document and policy analysis, systematic reviews, meta-analyses, survey development and implementation, conducting focus groups and interviews, program evaluations, preparation of submissions for ethics approval, and report writing. Antonia’s vast skill set allows her to contribute to diverse research projects and deliver insightful findings. Her proficiency in research methodologies and data analysis ensures the production of high-quality outcomes. Additionally, her experience in policy analysis and evaluation further enhances her ability to provide valuable insights within the healthcare industry. Antonia is fluent in English, Bulgarian and Russian and has a basic knowledge of Italian. She holds a Master of International Healthcare Management, Economics and Policy from SDA Bocconi University, Italy, a master’s degree in psychology, and a PhD in Special Education.

Interests/hobbies: Travelling, hiking, skiing, cooking, and listening to music

Michael del Aguila

Michael del Aguila comes to Evidinno with 25 years experience in consulting and work inside Life Sciences companies in support of market access and real world evidence generation.  This includes executive positions at Roche, Genentech, Bristol-Myers Squibb and Gilead. 

In BioPharma Michael led teams responsible for sponsored real world evidence and HEOR clinical and observational studies, as well as market access and pricing. His executive leadership in consulting services has included those same domains.

He is pleased to have the opportunity to lead Evidinno’s expansion in product offerings and customer base as we continue our growth trajectory. 

Interests/hobbies: Theater, live music, hiking and running

Jean Paul Collet

Jean-Paul is the Chief Scientific Officer at Evidinno. JP is a trained pediatrician with MSc in Health Economics and PhD in Epidemiology from McGill University. He’s been a Professor and Associate Head Research in the Department of Pediatrics at UBC since 2006. JP’s career in clinical research has been associated with receiving many competing grants (over $30 million), the supervision of over 50 students completing MSc, PhD or Postdoc, and numerous publications (200+) with many of them related to drug evaluation methodology, economic impact and outcomes research.

Interests/hobbies: Practicing Tai Chi and Hiking; Holistic approach for self-development; Philosophy

Masoud Pourrahmat

Masoud Pourrahmat acts as the Head of Operations at Evidinno. With a career spanning over a decade, he possesses extensive expertise in the field of HEOR. Masoud has demonstrated exceptional competence in overseeing and executing targeted or systematic literature reviews, meta-analyses, network meta-analyses, and surrogacy analyses of clinical outcomes. His contributions have encompassed diverse areas such as oncology, neurology, cardiology, endocrinology, immunology, and digital health, among others.

Interests/hobbies: Reading, history, cooking.

Mir Sohail Fazeli

Dr. Mir Sohail Fazeli is the President and Managing Director at Evidinno Outcomes Research Inc. He has over two decades of experience working within academia and industry acting as the principal investigator, project lead, and medical research consultant. His work in evidence synthesis covers a diverse range of methodologies, including systematic and targeted literature reviews of clinical trials and observational studies, meta-analyses, network meta-analyses, and complex statistical modelling studies.